Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 March 2022 | Story Lunga Luthuli | Photo Charl Devenish
UFS staff members
All smiles – pictured are inspired University of the Free State staff ready to live, serve with excellence, and care for the growth of the institution.

The Division of Organisational Development and Employee Well-being within the Department of Human Resources’ iRecognise initiative is another University of the Free State (UFS) initiative to appreciate and recognise staff dedication and excellence. 

Through the peer-to-peer iRecognise platform, UFS staff members have the opportunity to recognise colleagues from different units, divisions, faculties, and campuses. 

Natasha Nel, UFS Organisational Development specialist, said: “iRecognize is an open acknowledgment and expressed appreciation for employees’ contributions. A strong recognition culture can help individuals and organisations perform better. Employees, teams, and the university all benefit from frequent and meaningful feedback and appreciation.”

“It is a promotion of positive behaviour that supports individuals, teams, divisions, and departments in achieving the university’s vision and goals. The UFS wants to create a culture of mutual respect, reward, and recognition for employees at all levels in a non-monetary award based on significance,” she said.

The criteria for staff to recognise colleagues include timeliness, authenticity, and specificity, and the badges that staff members can use is also aligned with the university’s competency framework. The platform also includes an option to send recognition privately. 

“Employees who feel recognised and appreciated are more engaged, productive, and innovative, despite what may appear to be common sense. Employee appreciation is a potent motivator and reinforcer of positive behaviour,” Nel said.

Nel said: “Recognition reinforces acts and behaviour that improve everyone's working environment. Although recognition is free, it improves employee productivity, engagement, and quality of work.”

The recognition platform has other capabilities that the Division of Organisational Development and Employee Well-being would like to incorporate in the future, and staff can continue to nominate their colleagues for their excellence. 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept